Search

everythinglearnresearchcommunity

for

Search:↓

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

UV treatment can damage hair, so protection is advised.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Bexarotene gel shows promise as a new treatment for alopecia areata.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Hair and scalp disorders significantly affect self-esteem, and using cosmetic products like conditioners and styling aids can improve hair health and appearance.

Shampoos have evolved into multifunctional products with patented innovations for different hair needs and can include medicinal herbs for hair and scalp health.

Progesterone may help trans women with breast development and health, but more research is needed.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Liposomes could improve how skin care products work but are costly and not very stable.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Surfactants can protect or harm hair, skin, and nails, depending on their type and use.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Environmental, chemical, mechanical, and personal health factors can all damage hair and contribute to hair loss or changes in hair quality.

The document emphasizes early detection and treatment of men's skin conditions and recommends protective measures and appropriate treatments for different age groups.

Early intervention and protective measures are crucial for managing CIPA due to the lack of pain and standard treatment.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

COVID-19 can cause skin problems directly or from using protective gear and sanitizers, and knowing this can help treat patients better.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Ceramide helps protect African–American hair from breakage.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.